| Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors CM Morin, M LeBlanc, M Daley, JP Gregoire, C Merette Sleep medicine 7 (2), 123-130, 2006 | 1463 | 2006 |
| The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers M Daley, CM Morin, M LeBlanc, JP Grégoire, J Savard Sleep 32 (1), 55-64, 2009 | 903 | 2009 |
| The natural history of insomnia: a population-based 3-year longitudinal study CM Morin, L Bélanger, M LeBlanc, H Ivers, J Savard, CA Espie, C Mérette, ... Archives of internal medicine 169 (5), 447-453, 2009 | 615 | 2009 |
| Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents M Daley, CM Morin, M LeBlanc, JP Grégoire, J Savard, L Baillargeon Sleep medicine 10 (4), 427-438, 2009 | 537 | 2009 |
| Pharmacist intervention program for control of hypertension I Chabot, J Moisan, JP Grégoire, A Milot Annals of Pharmacotherapy 37 (9), 1186-1193, 2003 | 305 | 2003 |
| Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial L Baillargeon, P Landreville, R Verreault, JP Beauchemin, JP Grégoire, ... Cmaj 169 (10), 1015-1020, 2003 | 234 | 2003 |
| Potentially inappropriate prescriptions for older patients in long-term care C Rancourt, J Moisan, L Baillargeon, R Verreault, D Laurin, JP Grégoire BMC geriatrics 4 (1), 1-9, 2004 | 222 | 2004 |
| Burden of Diabetes on the Ability to Work MC Breton, L Guénette, MA Amiche, JF Kayibanda, JP Grégoire, J Moisan Diabetes Care 36 (3), 740-749, 2013 | 191 | 2013 |
| Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study C Bourgault, M Senecal, M Brisson, MA Marentette, JP Gregoire Journal of human hypertension 19 (8), 607-613, 2005 | 168 | 2005 |
| Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: a systematic review and meta-analysis HTV Zomahoun, L Guénette, JP Grégoire, S Lauzier, AM Lawani, ... International journal of epidemiology 46 (2), 589-602, 2016 | 165 | 2016 |
| Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes C Wahl, JP Gregoire, K Teo, M Beaulieu, S Labelle, B Leduc, B Cochrane, ... Healthc Q 8 (1), 65-70, 2005 | 156 | 2005 |
| Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients MM Goetghebeur, M Wagner, H Khoury, D Rindress, JP Grégoire, C Deal Cost Effectiveness and Resource Allocation 8 (1), 1-15, 2010 | 136 | 2010 |
| Determinants of discontinuation of new courses of antihypertensive medications JP Grégoire, J Moisan, R Guibert, A Ciampi, A Milot, M Gaudet, I Côté Journal of clinical epidemiology 55 (7), 728-735, 2002 | 112 | 2002 |
| Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia D Cooper, J Moisan, JP Grégoire The Journal of clinical psychiatry 68 (6), 818-825, 2007 | 108 | 2007 |
| Quality of life in hypertension: the SF-12 compared to the SF-36 I Côté, JP Grégoire, J Moisan, I Chabot Journal of Population Therapeutics and Clinical Pharmacology 11 (2), 2004 | 103 | 2004 |
| Health‐related quality of life in hypertension: impact of a pharmacy intervention programme I Côté, J Moisan, I Chabot, JP Grégoire Journal of clinical pharmacy and therapeutics 30 (4), 355-362, 2005 | 98 | 2005 |
| Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance L Guénette, J Moisan, MC Breton, C Sirois, JP Grégoire Diabetes & metabolism 39 (3), 250-257, 2013 | 89 | 2013 |
| Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniors J Moisan, M Gaudet, JP Grégoire, R Bouchard Gerontology 48 (1), 44-51, 2002 | 86 | 2002 |
| Tolerability of antihypertensive drugs in a community-based setting JP Grégoire, J Moisan, R Guibert, A Ciampi, A Milot, I Côté, M Gaudet Clinical therapeutics 23 (5), 715-726, 2001 | 76 | 2001 |
| Health-related quality-of-life measurement in hypertension: A review of randomised controlled drug trials I Cote, JP Grégoire, J Moisan Pharmacoeconomics 18, 435-450, 2000 | 75 | 2000 |
